Patents by Inventor Robert J. Mikhail

Robert J. Mikhail has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Topical Use Of Probiotic Bacillus Spores To Prevent Or Control Microbial Infections
    Publication number: 20110274676
    Abstract: Compositions including an isolated Bacillus species, spores or an extracellular product of B. coagulans, suitable for topical application, for inhibiting growth of yeast, fungus, bacteria or Herpes simplex virus are disclosed. Methods of inhibiting growth of yeast, fungus, bacteria or Herpes simplex virus by topical application of compositions that include an isolated Bacillus species, spores or an extracellular product of a B. coagulans strain are disclosed.
    Type: Application
    Filed: May 6, 2011
    Publication date: November 10, 2011
    Inventors: Sean Farmer, Robert J. Mikhail
  • Topical Use of Probiotic Bacillus Spores to Prevent or Control Microbial Infections
    Publication number: 20090186057
    Abstract: Compositions including an isolated Bacillus species, spores or an extracellular product of B. coagulans, suitable for topical application, for inhibiting growth of yeast, fungus, bacteria or Herpes simplex virus are disclosed. Methods of inhibiting growth of yeast, fungus, bacteria or Herpes simplex virus by topical application of compositions that include an isolated Bacillus species, spores or an extracellular product of a B. coagulans strain are disclosed.
    Type: Application
    Filed: February 12, 2009
    Publication date: July 23, 2009
    Applicant: Ganeden Biotech, Incorporated
    Inventors: Sean Farmer, Robert J. Mikhail
  • Topical use of probiotic spores to prevent or control microbial infections
    Patent number: 7507402
    Abstract: Compositions including an isolated Bacillus species, spores or an extracellular product of B. coagulans, suitable for topical application, for inhibiting growth of yeast, fungus, bacteria or Herpes simplex virus are disclosed. Methods of inhibiting growth of yeast, fungus, bacteria or Herpes simplex virus by topical application of compositions that include an isolated Bacillus species, spores or an extracellular product of a B. coagulans strain are disclosed.
    Type: Grant
    Filed: April 10, 1998
    Date of Patent: March 24, 2009
    Assignee: Ganeden Biotech, Inc.
    Inventors: Sean Farmer, Robert J. Mikhail
  • Probiotic lactic acid bacterium to treat bacterial infections associated with sids
    Publication number: 20080193429
    Abstract: Compositions including a non-pathogenic lactic acid-producing bacteria, such as a Bacillus species, spores or an extracellular product of B. coagulans, formulated for oral administration to the intestinal tract for inhibiting bacterial gastrointestinal infections are described. Methods and systems using the compositions for treating gastrointestinal infections, particularly sudden infant death syndrome (SIDS) are also disclosed.
    Type: Application
    Filed: April 17, 2008
    Publication date: August 14, 2008
    Inventors: Sean Farmer, Robert J. Mikhail
  • Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS
    Patent number: 7374753
    Abstract: Compositions including a non-pathogenic lactic acid-producing bacteria, such as a Bacillus species, spores or an extracellular product of B. coagulans, formulated for oral administration to the intestinal tract for inhibiting bacterial gastrointestinal infections are described. Methods and systems using the compositions for treating gastrointestinal infections, particularly sudden infant death syndrome (SIDS) are also disclosed.
    Type: Grant
    Filed: June 3, 1998
    Date of Patent: May 20, 2008
    Assignee: Ganeden Biotech, Inc.
    Inventors: Sean Farmer, Robert J. Mikhail